Endogenous cannabinoid system as a modulator of food intake

被引:234
作者
Cota, D
Marsicano, G
Lutz, B
Vicennati, V
Stalla, GK
Pasquali, R
Pagotto, U
机构
[1] St Orsola Marcello Malpighi Hosp, CRBA,Ctr Appl Biomed Res, Dept Internal Med & Gastroenterol, Endocrinol Unit, I-40138 Bologna, Italy
[2] Max Planck Inst Psychiat, Neuroendocrinol Grp, D-80804 Munich, Germany
[3] Max Planck Inst Psychiat, Mol Genet Behav Grp, D-80804 Munich, Germany
关键词
endocannabinoids; anandamide; obesity; Cannabis; SR141716A; food intake;
D O I
10.1038/sj.ijo.0802250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ability of Cannabis sativa (marijuana) to increase hunger has been noticed for centuries, although intensive research on its molecular mode of action started only after the characterization of its main psychoactive component Delta(9)-tetrahydrocannabinol in the late 1960s. Despite the public concern related to the abuse of marijuana and its derivatives, scientific studies have pointed to the therapeutic potentials of cannabinoid compounds and have highlighted their ability to stimulate appetite, especially for sweet and palatable food. Later, the discovery of specific receptors and their endogenous ligands (endocannabinoids) suggested the existence of an endogenous cannabinoid system, providing a physiological basis for biological effects induced by marijuana and other cannabinoids. Epidemiological reports describing the appetite-stimulating properties of cannabinoids and the recent insights into the molecular mechanisms underlying cannabinoid action have proposed a central role of the cannabinoid system in obesity. The aim of this review is to provide an extensive overview on the role of this neuromodulatory system in feeding behavior by summarizing the most relevant data obtained from human and animal studies and by elucidating the interactions of the cannabinoid system with the most important neuronal networks and metabolic pathways involved in the control of food intake. Finally, a critical evaluation of future potential therapeutical applications of cannabinoid antagonists in the therapy of obesity and eating disorders will be discussed.
引用
收藏
页码:289 / 301
页数:13
相关论文
共 125 条
[1]   EFFECTS OF MARIHUANA ON SOLUTION OF ANAGRAMS, MEMORY AND APPETITE [J].
ABEL, EL .
NATURE, 1971, 231 (5300) :260-&
[2]   CANNABIS - EFFECTS ON HUNGER AND THIRST/EUM OF [J].
ABEL, EL .
BEHAVIORAL BIOLOGY, 1975, 15 (03) :255-281
[3]   The effects of cannabinoids on the brain [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1999, 58 (04) :315-348
[4]   ORAL AND HYPOTHALAMIC INJECTIONS OF BARBITURATES, BENZODIAZEPINES AND CANNABINOIDS AND FOOD-INTAKE IN RATS [J].
ANDERSONBAKER, WC ;
MCLAUGHLIN, CL ;
BAILE, CA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (05) :487-491
[5]  
[Anonymous], PHARM MARIHUANA
[6]   Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors [J].
Arnone, M ;
Maruani, J ;
Chaperon, F ;
Thiebot, MH ;
Poncelet, M ;
Soubrie, P ;
LeFur, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :104-106
[7]   DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS [J].
BEAL, JE ;
OLSON, R ;
LAUBENSTEIN, L ;
MORALES, JO ;
BELLMAN, P ;
YANGCO, B ;
LEFKOWITZ, L ;
PLASSE, TF ;
SHEPARD, KV .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) :89-97
[8]   Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia [J].
Beal, JE ;
Olson, R ;
Lefkowitz, L ;
Larenstein, L ;
Bellman, P ;
Yangco, B ;
Morales, JO ;
Murphy, R ;
Powderly, W ;
Plasse, TF ;
Mosdell, KW ;
Shepard, KV .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (01) :7-14
[9]   Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid [J].
Beilin, M ;
Neumann, R ;
Belkin, M ;
Green, K ;
Bar-Ilan, A .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (03) :217-230
[10]   Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids [J].
Beinfeld, MC ;
Connolly, K .
NEUROSCIENCE LETTERS, 2001, 301 (01) :69-71